The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hobden Adrian N since 2007.
The trader's CIK number is 1191076.
At the time of the last reporting, Hobden Adrian N was the Pres. Myriad Pharmac of Myriad Pharmaceuticals, Inc.. (stock ticker symbol MYRX).
Also see all insider trading activities at Myriad Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | MYGN | 0 | $0 | 40,000 | $1,360,560 | 94,900 | $622,682 |
| 2008 | MYGN | 0 | $0 | 63,956 | $4,124,835 | 100,024 | $505,742 |
| 2007 | MYGN | 0 | $0 | 35,000 | $1,560,000 | 40,000 | $205,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | MYRX | 20,000 | $88,200 | 0 | $0 | 32,485 | $44,178 |
2. Myriad Pharmaceuticals, Inc. (MYRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-06-08 | MYGN | Option Ex | 37,158 | 11.41 | 423,824 |
| 2009-05-27 | MYGN | Option Ex | 40,000 | 2.39 | 95,600 |
| 2009-05-27 | MYGN | Sale | 40,000 | 34.01 | 1,360,560 |
| 2009-05-08 | MYGN | Option Ex | 17,742 | 5.82 | 103,258 |
| 2008-12-11 | MYGN | Option Ex | 20,000 | 4.78 | 95,620 |
| 2008-12-11 | MYGN | Sale | 20,000 | 60.60 | 1,212,060 |
| 2008-09-29 | MYGN | Option Ex | 21,068 | 5.12 | 107,973 |
| 2008-09-23 | MYGN | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-25 | MYGN | Sale | 15,000 | 68.54 | 1,028,130 |
| 2008-09-19 | MYGN | Option Ex | 992 | 5.12 | 5,084 |
| 2008-09-19 | MYGN | Sale | 992 | 66.00 | 65,472 |
| 2008-09-17 | MYGN | Option Ex | 500 | 5.12 | 2,562 |
| 2008-09-18 | MYGN | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-17 | MYGN | Sale | 500 | 66.49 | 33,245 |
| 2008-08-25 | MYGN | Option Ex | 27,464 | 5.12 | 140,753 |
| 2008-08-25 | MYGN | Sale | 27,464 | 65.03 | 1,785,928 |
| 2008-03-10 | MYGN | Option Ex | 10,000 | 5.12 | 51,250 |
| 2007-11-30 | MYGN | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-09-25 | MYGN | Option Ex | 20,000 | 5.12 | 102,500 |
| 2007-09-25 | MYGN | Sale | 20,000 | 50.00 | 1,000,000 |
| 2007-05-23 | MYGN | Sale | 10,000 | 40.00 | 400,000 |
| 2007-05-23 | MYGN | Option Ex | 10,000 | 5.12 | 51,250 |
| 2007-01-03 | MYGN | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-01-03 | MYGN | Sale | 5,000 | 32.00 | 160,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-04-16 | MYRX | Option Ex | 28,005 | 1.38 | 38,646 |
| 2010-03-18 | MYRX | Buy | 20,000 | 4.41 | 88,200 |
| 2010-03-02 | MYRX | Option Ex | 4,480 | 1.24 | 5,532 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hobden Adrian N (Pres. Myriad Pharmac of Myriad Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.